Blog

Australia’s medical cannabis market is projected to double from $600 million in 2024 to $1.2 billion by 2028, driven by increased patient access, telehealth services, and growing domestic production. Despite regulatory challenges, Australia is poised to become a global leader in the industry, with expanding exports and ongoing discussions about broader cannabis legalization.

Greece's medical cannabis industry is rapidly expanding, with Curity Pharma securing its operating license and joining key players like Tikun Olam Europe in shaping the market. With favorable regulations, a strong climate for cultivation, and increasing international trade, Greece is positioning itself as a major hub for medical cannabis in Europe.

Neobi is excited to contribute to this year’s CCX Annual Report with data driven insights derived
from several of our data sources. The Extracts category saw strong early-year growth but
declined in Q4, likely due to seasonal demand or competition. Innovative product variations and
strategic pricing adjustments could help sustain interest and improve market share.

2024 marks a watershed moment for the international cannabis market. While describing any year as ‘pivotal’ risks cliché, for this year it’s undeniably compelling: trends long anticipated by the industry have continued to materialize now just at an accelerated pace.

In 2024, cannabis companies saved significantly by reassessing ins...

Israeli tariffs on Canadian cannabis flower imports follow accusat...

Canada's cannabis industry grapples with unpaid excise taxes, prom...

CanMar, a prominent figure in health, wellness, and plant-based me...

Navigating the intricate web of cannabis regulations in Canada is ...